Modernizing Automation Solutions: Digital Transformation Optimizes Production, Quality, And Compliance

Honeywell has successfully transformed Fermion's new manufacturing facility by implementing advanced automation solutions tailored for the pharmaceutical and life sciences sectors. This collaboration emphasizes compliance with stringent industry standards, resulting in an efficient and timely rollout that enhances production, quality, and regulatory adherence. This case study illustrates how digital transformation is pivotal in modernizing manufacturing processes, particularly in the face of rising demands for innovative therapies.

As the pharmaceutical landscape evolves, manufacturers of Active Pharmaceutical Ingredients (APIs) are under pressure to adopt cutting-edge technologies to meet market needs. The integration of advanced process control and safety technologies not only mitigates risks associated with new production methods but also significantly boosts operational performance. With the increasing prevalence of high-potency active pharmaceutical ingredients (HPAPIs), the necessity for specialized manufacturing capabilities becomes paramount. Fermion's investment of EUR 35 million in a highly automated facility at its Hanko plant exemplifies a commitment to modernization and compliance. Partnering with Honeywell, the facility features state-of-the-art automation systems that streamline processes, enhance worker safety, and improve overall efficiency.

Access the full case study to learn more.